1. Genetic tests
  2. Breast and Ovarian Cancer, HBOC, Familial (gene panel)

Breast and Ovarian Cancer, HBOC, Familial (gene panel)

Genetic test Export to PDF
Full name:
Breast and Ovarian Cancer, HBOC, Familial (gene panel)
Test type:
Clinical
Test specialty:
Molecular Genetics
Test purpose:
Mutation confirmation,
Post-natal Diagnosis,
Predictive and Pre-symptomatic diagnosis,
Prenatal diagnosis
Specimen:
Peripheral (whole) blood on EDTA
Method category:
Sequence analysis: entire coding region
Deletion/duplication analysis
Method technique:
Next Generation Sequencing (NGS)
Laboratory:
Centrum Menselijke Erfelijkheid - KUL
RIZIV code:
565552-565563
EQA:
  • 2015 Familial Breast/Ovarian Cancer (full version) EMQN
  • 2016 Familial Breast/Ovarian Cancer (full version) EMQN
  • 2017 Familial Breast/Ovarian Cancer (full version) EMQN
  • 2018 Familial Breast/Ovarian Cancer (full version) EMQN
  • 2019 Hereditary Breast and Ovarian Cancer (Panel) EMQN
  • 2022 Hereditary Breast and Ovarian Cancer (panel testing) EMQN
Accreditation (ISO 15189):
2021-07-08 / 2026-02-02
Turnaround time (maximum):
4 - 6 months
Document(s):
Created:
18 Jul 2019 - 09:49
Changed:
11 Dec 2023 - 10:56
URL:
https://laboboeken.nexuzhealth.com/pboek/internet/GHB%20CME/13372
  • Breast/ ovarian cancer (15 genes) - KUL
    Gene % of coding sequence sufficiently covered to detect heterozygous mutations Copy number variation Comments
    RAD51C 100.00 1
    RAD51D 100.00 1
    BRCA1 100.00 1
    BRCA2 100.00 1
    TP53 100.00 1
    CHEK2 100.00 1
    MLH1 100.00 1
    MSH2 100.00 1
    MSH6 100.00 1
    BRIP1 100.00 1
    ATM 100.00 1
    PALB2 100.00 1
    CDH1 100.00 1
    BARD1 100.00 1
    PTEN 100.00 1